Skip to content Skip to footer
Menomune-A/C/Y/W-135: Benefits, Reviews, Info, Side Effects!
Rx Details
Menomune-A/C/Y/W-135
Menactra, Menveo, Meningococcal polysaccharide vaccine
Meningococcal polysaccharide vaccine (Menomune-A/C/Y/W-135)
Prescription
Vaccine
Vaccines
Vaccine
protection against meningococcal disease, prevention of meningitis caused by Neisseria meningitidis, coverage against serogroups A, C, Y, and W-135, reduced risk of meningococcal outbreaks, support for travelers to endemic areas, immunization for at-risk populations
Fatigue, Fever, Headache, Muscle Pain, Nausea, Pain At Injection Site, Redness At Injection Site, Swelling At Injection Site
Menomune-A/C/Y/W-135 is a meningococcal polysaccharide vaccine used to help prevent infection by certain groups of Neisseria meningitidis bacteria. The typical dosage for Menomune is a single 0.5 mL dose administered subcutaneously. However, it’s important to follow the specific recommendations provided by healthcare professionals or the guidelines set by health authorities, as they may vary based on age, health status, and other factors. Always consult with a healthcare provider for the most accurate and personalized information.
Meningococcal disease
Generally safe vaccine for meningococcal disease.
No Interactions Reported
$100 – $200
$15,000.00

A Synopsis of

Menomune-A/C/Y/W-135

Menomune-A/C/Y/W-135 is a vaccine that provides protection against four strains of meningococcal bacteria: A, C, Y, and W-135. Meningococcal disease is a serious infection that can lead to meningitis, septicemia, and even death if left untreated. This vaccine is recommended for individuals who are at increased risk of exposure to these bacteria, such as college students living in dormitories, military personnel, and travelers to regions where meningococcal disease is prevalent.

Menomune-A/C/Y/W-135 is typically administered as a single injection and provides immunity for up to five years. It is important to receive this vaccine before potential exposure to meningococcal bacteria, as it takes about two weeks for the body to develop protection after vaccination. Common side effects of Menomune-A/C/Y/W-135 may include redness, swelling, or pain at the injection site, as well as mild fever or headache. These side effects are usually mild and resolve on their own within a few days.

As a medical professional, I recommend Menomune-A/C/Y/W-135 to individuals who are at risk of meningococcal disease, as it is a safe and effective way to prevent this serious infection. It is important to stay up to date on vaccinations and follow the recommended schedule for booster doses to ensure continued protection. If you have any questions or concerns about Menomune-A/C/Y/W-135 or any other vaccines, please do not hesitate to speak with your healthcare provider. Your health and well-being are our top priorities, and we are here to help you make informed decisions about your healthcare.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN